Vivjoa
My Prescription
Payment
Select pharmacy
$3,267.69
$30.00 due at pharmacy
$3,267.69 - $30.00 = $3,237.69
$3,237.69 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$3,267.69
Print or send this coupon to your phone
AlbertsonsPowered byAbout Vivjoa
Drug Details
Oteseconazole, marketed under the brand name Vivjoa, is an FDA-approved antifungal medication used to reduce the recurrence of vaginal yeast infections, specifically recurrent vulvovaginal candidiasis (RVVC). This medication is intended for individuals who are not capable of becoming pregnant, as it may cause harm to unborn babies and remains in the body for approximately two years after the final dose. Oteseconazole functions by inhibiting the growth of yeast by preventing the formation of a critical component of the fungal cell wall and causing a toxic buildup within the fungus, ultimately leading to its death. While it effectively manages chronic vaginal yeast infections, common side effects can include headache and nausea. Oteseconazole is available only as a brand-name medication and should be used under the guidance of a healthcare professional.
Price history for Vivjoa
18 Capsule Therapy Packs, 150MG
Average retail price for Vivjoa
Average SaveHealth price for Vivjoa
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Vivjoa dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 150MG | 18 Capsule Therapy Packs | $3,267.69 | $181.54 |
Vivjoa FAQs
Vivjoa is used for the treatment of recurrent vulvovaginal candidiasis, commonly known as yeast infections, in females who are not of reproductive potential.
Yes, Vivjoa (oteseconazole) is available in the USA. It was approved by the FDA for use in treating recurrent vulvovaginal candidiasis.
Vivjoa (oteseconazole) is an antifungal medication that has been shown to be effective in treating recurrent vulvovaginal candidiasis (RVVC) in clinical trials. It is specifically indicated for use in women who are not of reproductive potential. The effectiveness of Vivjoa was demonstrated in studies where it significantly reduced the incidence of RVVC episodes compared to placebo. However, individual responses to the medication can vary, and it is important for patients to discuss their specific condition and treatment options with their healthcare provider.
Vivjoa (oteseconazole) works by inhibiting the enzyme lanosterol 14-demethylase, which is crucial for the synthesis of ergosterol, an essential component of fungal cell membranes. By disrupting the production of ergosterol, Vivjoa compromises the integrity of the fungal cell membrane, leading to cell death and helping to treat fungal infections.